New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2013
09:02 EDTAEZSAeterna Zentaris upgraded to Buy from Hold at MLV Equity
MLV Equity believes Aeterna Zentaris' pipeline drugs, AEZS-108 and AEZS-130, have substantial value and that DSMB recommendation on Perifosine in Q1 could act as a catalysts. Price target is $5.50.
News For AEZS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2016
08:32 EDTAEZSAeterna Zentaris files international patent application for Zoptrex method
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use